188 related articles for article (PubMed ID: 21812190)
1. [Making antibiotic therapy easier to use. A welcome advance for those with cystic fibrosis].
Sabourin G
Perspect Infirm; 2011; 8(4):54-5. PubMed ID: 21812190
[No Abstract] [Full Text] [Related]
2. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
Châtain P
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
[No Abstract] [Full Text] [Related]
3. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
[TBL] [Abstract][Full Text] [Related]
4. [Ochrobactrum anthropi bacteremia in a child with cystic fibrosis].
Yagüe-Muñoz A; Gregori-Roig P; Valls-López S; Pantoja-Martínez J
Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):137-8. PubMed ID: 19811858
[No Abstract] [Full Text] [Related]
5. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
[TBL] [Abstract][Full Text] [Related]
6. Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.
Med Lett Drugs Ther; 2013 Jun; 55(1419):51-2. PubMed ID: 23797798
[No Abstract] [Full Text] [Related]
7. Value of inhaled antibiotics in cystic fibrosis patients.
Wunderlich P; Paul KD; Wehner J
Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
[TBL] [Abstract][Full Text] [Related]
8. Inhaled antibiotics.
Tiddens H
Pediatr Pulmonol Suppl; 2004; 26():92-4. PubMed ID: 15029611
[No Abstract] [Full Text] [Related]
9. [Use of inhaled tobramycin in patients with cystic fibrosis].
Chermenskiĭ AG; Gembitskaia TE
Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
[TBL] [Abstract][Full Text] [Related]
10. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
11. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
Stelmach I; Korzeniewska A; Stelmach W
Respiration; 2008; 75(2):178-81. PubMed ID: 17435382
[TBL] [Abstract][Full Text] [Related]
12. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
Foucaud P; Borel B; Charara O; Nathanson S; Petitprez P; Pin I
Rev Pneumol Clin; 2002 Jun; 58(3 Pt 1):131-8. PubMed ID: 12486796
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis.
Hubert D; Leroy S; Nove-Josserand R; Murris-Espin M; Mely L; Dominique S; Delaisi B; Kho P; Kovarik JM
J Cyst Fibros; 2009 Sep; 8(5):332-7. PubMed ID: 19651542
[TBL] [Abstract][Full Text] [Related]
14. Tobramycin ototoxicity. Repeated courses of high dosage treatment in children with cystic fibrosis.
Thomsen J; Friis B; Jensen K; Bak-Pedersen K; Larsen PK
J Antimicrob Chemother; 1979 May; 5(3):257-60. PubMed ID: 479061
[No Abstract] [Full Text] [Related]
15. [Cystic fibrosis: current therapy. Antibiotics].
Tamm M; Héritier F; Rappaz I; Schaad UB
Schweiz Med Wochenschr Suppl; 2000; 122():33S-37S. PubMed ID: 12536469
[No Abstract] [Full Text] [Related]
16. High dosage tobramycin treatment of children with cystic fibrosis. Bacteriological effect and clinical ototoxicity.
Thomsen J; Friis B
Int J Pediatr Otorhinolaryngol; 1979 Jul; 1(1):33-40. PubMed ID: 553884
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
Vávrová V; Lochmann O; Suková B; Copová M; Zapletal A; Absolonová V; Houstĕk J
Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
[No Abstract] [Full Text] [Related]
18. Cystic fibrosis: intravenous treatment at home.
Catchpole A
Nurs Times; 1989 Mar 22-28; 85(12):40-2. PubMed ID: 2717454
[No Abstract] [Full Text] [Related]
19. Tobramycin inhalation solution (Bethkis) for cystic fibrosis.
Med Lett Drugs Ther; 2014 Jun; 56(1445):51-2. PubMed ID: 24956309
[No Abstract] [Full Text] [Related]
20. Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
Fitzpatrick SB; Rosenstein BJ
Clin Pediatr (Phila); 1983 Sep; 22(9):628-30. PubMed ID: 6224623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
